Treatment adherence in tyrosinemia type 1 patients
نویسندگان
چکیده
منابع مشابه
Comment on Pancreatitis in Type 1 Tyrosinemia
Address for Correspondence: Dr. Hakim Rahmoune, Department of Pediatrics, Setif University Hospital, Setif, Algeria Phone: +213-550123279 e-mail: [email protected] Received: 7 August 2016 Accepted: 16 January 2017 • DOI: 10.4274/balkanmedj.2016.1209 Available at www.balkanmedicaljournal.org Cite this article as: Rahmoune H, Boutrid N, Amrane M, Bioud B. Comment on Pancreatitis in Type 1 T...
متن کاملType 1 Tyrosinemia with Hypophosphatemic Rickets; a Case Report
Background: Tyrosinemia type 1 is an autosomal recessive metabolic disorder, which typically affects liver and kidneys. It is caused by a defect in fumarylacetoacetate hydrolase or fumarylacetoacetase (FAH) enzyme, the final enzyme in the tyrosine degradation pathway. The disease typically manifests as early onset type in early infancy with acute hepatic crisis with hepatomegaly and bleeding te...
متن کاملAdherence to Treatment Based on Social Support and Coping Strategies in Patients with Type 2 Diabetes
Background: According to the growing prevalence of type 2 diabetes, the present study aimed to predict adherence to treatment based on social support variables and coping strategies to reduce the severity of this disease. Materials and methods: In this cross-sectional study, 392 men and women with type 2 diabetes were evaluated using purposeful and convenient sampling. Wax social support and t...
متن کاملThe effect of family-centered care on adherence to treatment in patients with type 2 diabetes
Background: Due to the prevalence of mortality due to complications of diabetes, this disease has focused on the health system.The family as the most basic pillar of society is responsible for the proper care of the patient with diabetes. Therefore, this study aimed to determine the effect of family-based care on adherence to treatment in type 2 diabetic patients. Materials & Methods: In quasi...
متن کاملGoldenhar syndrome and hereditary tyrosinemia type 1.
We report a case of Goldenhar syndrome and hereditary tyrosinemia type 1 (HTT1), to our knowledge an association not previously described. This case further increases the diversity of observations and clinical descriptions of patients with this complex syndrome. We discuss pathogenetic aspects, and demonstrate further evidence of the effectiveness of 2-(2-nitro-4-trifluoromethyl benzoyl)-1,3-cy...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Orphanet Journal of Rare Diseases
سال: 2021
ISSN: 1750-1172
DOI: 10.1186/s13023-021-01879-1